Product Description
Machine-to-machine (commonly abbreviated as M2M) refers to direct communication between devices using any communication channel, both wired and wireless. The M2M adoption of healthcare, sometimes called telemedicine, combines medical devices and communication technologies to monitor disease and symptoms, and also helps doctors communicate directly.
The Machine to Machine (M2M) Healthcare market revenue was xx Million USD in 2019, grew to xx Million USD in 2023, and will reach xx Million USD in 2031, with a CAGR of xx during 2024-2031.
Considering the influence of COVID-19 on the global Machine to Machine (M2M) Healthcare market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.
This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.
Under COVID-19 Outbreak, how the Machine to Machine (M2M) Healthcare Industry will develop is also analyzed in detail in Chapter 1.8 of this report.
Major Players in Machine to Machine (M2M) Healthcare market are:
Cradlepoint
InVMA Ltd.
AirStrip Technologies
IBM
SmartM2MSolutions
BL Healthcare
Deutsche Telekom
QxMD Software
NeuroVigil
Apple
Ingenious Med
Cisco Networks
Microsoft
Most important types of Machine to Machine (M2M) Healthcare products covered in this report are:
Wired Technologies
Wireless Technologies
Cellular Technologies
Most widely used downstream fields of Machine to Machine (M2M) Healthcare market covered in this report are:
Patient Monitoring Systems
Fall Detector
Smart Pill Dispenser
Telemedicine
Major Regions or countries covered in this report:
North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others
In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.
In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.
In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.